A Community-based Solution for Nocturia: Integrating Digital Technology and Behavioral Interventions
A Novel Community-based Solution for Nocturia: Integrating Digital Technology and Multi-strategy Interventions
1 other identifier
interventional
50
1 country
1
Brief Summary
Nocturia is a prevalent and distressing condition among older adults in Taiwan, significantly impacting sleep quality, mental health, and fall risks. This pilot study evaluates a novel community-based management model that integrates digital health technology with behavioral therapy. Participants aged 55 years or older experiencing nocturia (≥2 voids/night) will be cluster-randomized into an intervention group or a control group. The intervention group will utilize a voiding diary and a non-contact home uroflowmetry (HUFM) device to track voiding patterns and receive real-time feedback. This data-driven approach is combined with personalized lifestyle guidance (e.g., fluid restriction and leg elevation) and psychiatric screening for sleep and mood disorders. The primary objective is to evaluate the reduction in nocturnal voids and improve quality of life, while exploring the potential to reduce dependence on medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2026
CompletedStudy Start
First participant enrolled
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
July 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
July 29, 2026
March 1, 2026
6 months
April 7, 2026
July 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Nocturia Frequency
Analyze changes in the frequency of nocturia by Overactive Bladder Symptom Score(OABSS) that is a validated, four-question diagnostic tool used to assess the severity of overactive bladder (OAB) symptoms based on daytime frequency, night-time frequency, urgency, and urge incontinence.
Baseline,3months,6months after randomization
Secondary Outcomes (5)
Sleep Quality
Baseline,3months,6months after randomization
Mental Health
Baseline,3months,6months after randomization
QoL
Baseline,3months,6months after randomization
Fall and emergency
Baseline,3months,6months after randomization
Anxiety
Baseline,3months,6months after randomization
Study Arms (2)
Intervention Group
EXPERIMENTALThe intervention group will utilize a voiding diary and a non-contact home uroflowmetry (HUFM) device to track voiding patterns and receive real-time feedback. This data-driven approach is combined with personalized lifestyle guidance (e.g., fluid restriction and leg elevation) and psychiatric screening for sleep and mood disorders.
Control Group
NO INTERVENTIONA general routine health eduation and follow-up
Interventions
This intervention involves the use of an electronic urine record device that tracks nocturia episodes. The device syncs with a digital app, providing real-time feedback and allowing participants to monitor their urinary patterns. This intervention aims to help participants better understand their nocturia and improve lifestyle management strategies, including sleep hygiene and fluid intake control.
By recording fluid intake, voiding time, urine volume and urinary incontinence for 2-3 consecutive days each month over a 6-month period. It helps research group accurately analyze the condition, distinguish between bladder function problems and Polyuria, and evaluate treatment effectiveness.
Eligibility Criteria
You may qualify if:
- Baseline nocturia frequency ≥ 2 times/night (confirmed by subjective report or simplified questionnaire).
- Ability to operate LINE on a smartphone or have a caregiver assist with completing the electronic urinary diary.
You may not qualify if:
- Acute urinary tract infection
- Uncontrolled heart failure
- Serum sodium \< 130 mEq/L
- Underwent urological surgery within the past three months
- Major psychiatric or neurological disorder in an active phase, (GDS-15\>5)
- Participation in other clinical trials related to nocturia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yunlin HI-HOPE Community Hub
Douliu, Taiwan
Related Publications (1)
Tsai VFS, Tsai YC, Yang SSD, Li MW, Pong YH, Tsai YT. An Emerging Trend of At-Home Uroflowmetry-Designing a New Vibration-Based Uroflowmeter with Artificial Intelligence Pattern Recognition of Uroflow Curves and Comparing with Other Technologies. Diagnostics (Basel). 2025 Jul 21;15(14):1832. doi: 10.3390/diagnostics15141832.
PMID: 40722581BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2026
First Posted
July 29, 2026
Study Start
April 8, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
July 29, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share